Home > Income Statement > AUROBINDO PHARMA

AUROBINDO PHARMA
Consolidated Net Profit

    Back to Income Statement
AUROBINDO PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best 1M Momentum Mid Cap Stocks
COMMUNITY POLL
for AUROBINDO PHARMA
Please provide your vote to see the results

AUROBINDO PHARMA Last 5 Year Consolidated Net Profit History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Consolidated Net Profit ₹1,928 Cr₹2,648 Cr₹5,335 Cr₹2,845 Cr₹2,365 Cr

What is the latest Consolidated Net Profit of AUROBINDO PHARMA ?

The latest Consolidated Net Profit ratio of AUROBINDO PHARMA is ₹1,928 Cr based on Mar2024 Consolidated results.
Year Consolidated Net Profit
Mar2024₹1,928 Cr
Mar2023₹2,648 Cr
Mar2022₹5,335 Cr
Mar2021₹2,845 Cr
Mar2020₹2,365 Cr

How is Consolidated Net Profit of AUROBINDO PHARMA Trending?

Years Consolidated Net Profit % Change
Mar2024 ₹1,928 Cr
-27.21
Mar2023 ₹2,648 Cr
-50.36
Mar2022 ₹5,335 Cr
87.51
Mar2021 ₹2,845 Cr
20.32
Mar2020 ₹2,365 Cr -

Compare Consolidated Net Profit of peers of AUROBINDO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
AUROBINDO PHARMA ₹67,294.4 Cr 0.1% 9.5% 4.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹411,306.0 Cr -2.5% 7.6% 4.7% Stock Analytics
DIVIS LABORATORIES ₹150,343.0 Cr -3% 3.4% 61.5% Stock Analytics
CIPLA ₹117,323.0 Cr -1.6% 3% -3.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹108,619.0 Cr -0.3% 9% 22.3% Stock Analytics
DR REDDYS LABORATORIES ₹95,941.5 Cr -1.2% 2.9% -6.4% Stock Analytics


AUROBINDO PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
AUROBINDO PHARMA

0.1%

9.5%

4.2%

SENSEX

-1.8%

2.7%

5%


You may also like the below Video Courses